Dermatology News

Since the 1940s, the misuse and overuse of antibiotics have morphed the evolution of Staphyloccoccus aureus, causing microbes to become resistant to the drugs created to fight these infections.

Early detection and diagnosis, as well as collaboration with local medical personnel, are key elements in controlling an ongoing epidemic of cutaneous leishmaniasis among Syrian refugees in Lebanon, according to recent findings.

PHILADELPHIA — Novel oxazolidinone antibacterial tedizolid for treatment of patients with acute bacterial skin and skin structure infections showed a better gastrointestinal adverse event profile compared with linezolid, according to phase 3 study data presented at IDWeek 2014.

The ammonia-oxidizing bacteria, Nitrosomonas, may have a future as a self-regulating topical delivery agent for nitrite and nitric oxide to the skin, according to data from a poster presented at the 5th American Society for Microbiology Conference on Beneficial Microbes.

In 2011, the Infectious Diseases Society of America published its first clinical practice guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Methicillin-resistant Staphylococcus aureus is known to cause skin infections as well as other types of infections within the general community, and could lead to pneumonia, bloodstream or surgical site infections within the health care setting, according to the CDC.

WASHINGTON, D.C. — Among patients with community-acquired Staphylococcus aureus who presented to the ED with closed skin abscesses, CC8-300 was the most common MRSA colonizing strain, according to data presented at ICAAC 2014.

WASHINGTON, D.C. — An early positive clinical response to oritavancin within 48 to 72 hours was highly predictive of an eventual cure in adult patients with acute bacterial skin and skin structure infections, according to recent data presented at ICAAC 2014.

Ionic liquids may be an effective resource in combating bacterial skin infections protected by biofilm, according to recent study data published in the Proceedings of the National Academy of Science.

Cubist Pharmaceuticals voluntarily recalled nine lots of daptomycin for injection because of foreign particulate matter found in reconstituted vials, according to a press release from the manufacturer.